Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael T, Guskey"'
Autor:
Doral Fredericks, Clive Ballard, Alberto J. Espay, Candace Andersson, Michael T. Guskey, Bruce Coate, Stewart A. Factor, Niccole J. Larsen, James C. Norton, Joseph H. Friedman, Joaquin A. Vizcarra, Daniel Weintraub, Anthony E. Lang
Publikováno v:
Movement Disorders. 33:1769-1776
Background: PD psychosis is often associated with cognitive impairment, including dementia, and involves dopaminergic, serotonergic, and cholinergic mechanisms. Objective: To evaluate the differential effect of the antipsychotic pimavanserin, a selec
Autor:
Marc Cantillon, Jason L. Aldred, James C. Norton, Michael T. Guskey, Bruce Coate, Gustavo Alva, Daryl DeKarske
Publikováno v:
CNS Spectrums. 25:301-301
Study Objectives:Depression occurs in ~50% of Parkinson’s disease (PD) patients, increases in severity and duration as the disease progresses, and is associated with increased morbidity. Improvement of depression in PD patients is correlated with r
Autor:
Alberto J, Espay, Michael T, Guskey, James C, Norton, Bruce, Coate, Joaquin A, Vizcarra, Clive, Ballard, Stewart A, Factor, Joseph H, Friedman, Anthony E, Lang, Niccole J, Larsen, Candace, Andersson, Doral, Fredericks, Daniel, Weintraub
Publikováno v:
Movement Disorders
Background: PD psychosis is often associated with cognitive impairment, including dementia, and involves dopaminergic, serotonergic, and cholinergic mechanisms. Objective: To evaluate the differential effect of the antipsychotic pimavanserin, a selec
Publikováno v:
The American Journal of Geriatric Psychiatry. 27:S175
Introduction The objective of this post hoc analysis was to evaluate whether Alzheimer's disease (AD) patients with psychosis who experience an improvement in their hallucinations and delusions with pimavanserin treatment also experience an improveme
Autor:
Brian T. Tsuji, Michael T Guskey
Publikováno v:
Pharmacotherapy. 30:80-94
Resistance to antibiotics among gram-positive bacteria, especially enterococci and staphylococci, has led to the need to develop new antibiotics. Vancomycin, a glycopeptide antibiotic, has been used for over 3 decades to treat serious methicillin-res